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ABSTRACT
Global health policymakers have identified Myanmar as a source of high 
drug resistance and informal pharmaceutical markets in need of tighter 
state regulation. The World Health Organization drafted a Global Action 
Plan on antibiotic resistance (often referred to as antimicrobial resistance) 
that seeks to address it. Myanmar is one of over a hundred countries that 
has followed the World Health Organization’s prescription and drafted its 
own National Action Plan. Through participating in the everyday life of 
a family pharmacy, we observed that in practice the outcomes of global 
plans for AMR, such as regulating access to antibiotics, are shaped by 
people’s limited access to affordable health care, low salaries, and the 
military’s authoritarian role in Myanmar politics. We followed how nego-
tiations between state officials and drug vendors evolved towards 
a mutual understanding (as opposed to following written rules) after 
a Food and Drug Administration raid, intended to enforce the regulation 
of the sales of illegal medicines. Rather than uncritically pushing state- 
centric action, those working to promote the regulation of medicines 
must attend more carefully to how different modes of political authority 
and governance, combined with histories of health provision, shape drug 
policy in practice. Otherwise, they risk contributing, if not intensifying, 
already existing health and social injustices, whilst also failing to generate 
their intended outcomes, such as meaningful changes to antibiotic sales 
and reductions in resistance.
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The World Health Organization (WHO) and other global stakeholders increasingly report that anti-
microbial resistance (AMR) is an emerging threat to all nation-states. Low- and middle-income 
countries (LMIC) are frequently singled out as sources of particularly high AMR, commonly attributed 
to their ‘irrational’ use of, and the availability of, ‘unregulated’ antibiotics (Broom et al., 2020a; 
Holloway et al., 2016; Zellweger et al., 2017). The WHO has developed a Global Action Plan (GAP) 
on AMR with the goal ‘ . . . to ensure, for as long as possible, continuity of successful treatment and 
prevention of infectious diseases with effective and safe medicines’ (World Health Organization, 
2015, p. 1). Member states are expected to develop their own National Action Plans (NAP) in line with 
the GAP, following its prescriptions to better surveil, regulate, and rationalise antibiotic usage (World 
Health Organization, 2015).
Here, we follow Bacchi’s approach (Bacchi, 2016) to policy in reading the WHO GAP and NAP as 
‘reactions to presumed problems’, which attempt to dictate how antibiotics and their associated 
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peoples should be governed (i.e. globally via the WHO and nationally via state governments) and the 
expected means to do so (state surveillance, regulation, and stewardship programmes). The WHO 
AMR GAP acknowledges that nation-states have variable resources available and thus differing 
abilities to govern antibiotics. This is posed as a particular challenge for many LMIC member- 
states, where the availability of antibiotics and their ‘irrational’ uses are shaped through their state- 
market formations, which in many cases differ from those of high-income countries. Such LMIC 
member-states may also lack equivalent government infrastructure and investments, as well as 
having differing degrees of state sovereignty, modes of political governance and means of enacting 
the rule of law. This raises questions about the success and possible negative consequences of the 
WHO’s apparently default promotion of nation-states as the primary governing bodies through 
which global health policies, like antibiotic regulations, are expected to be enforced. For example, 
the WHO AMR secretariat states its support for member states to ‘[. . .] provide leadership to 
strengthen medicines regulatory systems at national and regional levels’ (World Health 
Organization, 2015, p. 14)’. This technical language and the WHO’s GAP document as a whole 
promote national regulations as a necessary means for governing antimicrobials while refraining 
from explicit discussion or prescriptions on political governance, enactment of rule of law and 
political principles.
We focus on Myanmar, a formally quasi-democratic state that continues to take an authoritarian 
approach to national security over the health and welfare of its citizens as the recent 2021 military 
coup amply demonstrates. Prior to the coup, the majority of these citizens were forced to seek health 
care and medicines through underfunded state facilities, private clinics, pharmacies, and unregu-
lated markets. Similar to the WHO GAP, Myanmar’s 2017 draft NAP is a technical policy document 
that does not describe its form of government, state-market arrangements, or other practices 
relevant to shaping antimicrobial use (National Action Plan for Containment of Antimicrobial 
Resistance: Myanmar (NAP AMR), 2017). The document frames AMR in line with the WHO GAP’s 
objectives (The Ministry of Health and Sports, 2018, p. 48) and states that the Myanmar government 
was at the stage of exploration and initial implementation of laboratory surveillance, AMR aware-
ness, improving hygiene/sanitation and drug regulation, with nationwide scale up due to be 
completed in 2022. The Food and Drug Administration (FDA) is the actor responsible for aspects 
of NAP Objective 4 that pertains to the regulation of medicines, including enforcing quality 
standards of antimicrobials. The draft NAP, however, states that they have ‘limited human resources 
for regulatory enforcement’ and ‘lack effectiveness at the field level’ (National Action Plan for 
Containment of Antimicrobial Resistance: Myanmar (NAP AMR), 2017, pp. 17, 19). Despite this, the 
FDA has begun to incorporate antibiotic-related awareness messages into its drug inspections, 
including warnings like, ‘antibiotics should only be sold under a prescription’ (Food and Drug 
Administration, 2020; Shwe Yee San Myint 2014b; The Ministry of Health and Sports, 2018). In this 
paper, we draw critical attention to examples of how drug regulation is enacted or not in Yangon, the 
previous capital city, and also the financial and social hub of Myanmar, to highlight some of the 
consequences of merely translating the WHO’s GAP into action without considering how the history 
of military rule and fragmented state infrastructure in Myanmar shape access and regulation of 
medicines. We begin with a vignette, of a drug raid in an industrial poor workers’ suburb of Yangon.
A food and drug administration raid
One morning early in 2019 during our ethnographic fieldwork at Sein Se Saing (Sein medicine shop), 
we noticed several boxes of injectable vitamins were missing. U Kyaw was shifting them and other 
medicines into a storage space at the back of their shop. U Kyaw and Aunty Moe are a couple that 
runs their small family-owned business, Sein, without any formal clinical or pharmaceutical creden-
tials, a common practice in Myanmar. News of an FDA inspection was circulating in the neighbour-
hood. Despite this, Aunty Moe was not anxious, because as she later told us, they had evaded such 
inspections before, often by closing their shop early. Just as she was preparing set say (an assortment 
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of medicines, usually 3–4 pills per packet), which included antibiotics, for a regular customer, an FDA 
van arrived and 11 government officials got out and surrounded the entrance of Sein. Without giving 
her a chance to say anything, an FDA inspector sternly reprimanded her:
You are mixing drugs? Are antibiotics included in here? [he looked at the packet] . . . Never sell antibiotics 
without a prescription. Antibiotic resistance is happening because you are selling them. This was recently 
announced by MOHS. They are now drawing up the policy . . . If we see you selling antibiotics after the policy 
is out, we will put you in jail.
Shortly afterwards, the inspectors started confiscating several boxes of medicines. One of them 
asked U Kyaw why he had analgesine injections. He answered that it was because the doctors and 
nurses come to buy them. She responded angrily, almost shouting, ‘Watch your mouth, as a health 
officer we would never buy it from place like this!’ While another instructed:
If people come to buy antibiotics, only sell it to those who bring their prescription books and don’t cut up the 
pills; you must sell them with their packaging. Because you mix medicines, people don’t go to clinics and 
hospitals anymore . . . When people come to the hospital, they are resistant to the medicines.
The FDA confiscated more than 20 different types of medicines, mostly unregistered medicines, a net 
worth of approximately 350 USD. After leaving leaflets with instructions on how to sell medicines, 
they left, leaving Aunty Moe close to tears. Not only was she upset by how these ‘young’ officials 
spoke to them, their elders, but also because they had suffered a huge financial loss. Despite what 
the inspectors had said, Aunty Moe and U Kyaw were left with a sense of confusion and injustice as to 
why the incident occurred.
For those working in the field of global health, the above encounter may seem to be an 
example of how state employees can act to regulate the sale of unregistered pharmaceuticals 
and the unqualified provision of antibiotics. These practices may also be accepted as necessary 
measures to contribute towards global imperatives to reduce antibiotic consumption, ensure 
patient safety and medicine quality. Such an uncritical interpretation is problematic for 
Myanmar, on at least three accounts. First, it fails to engage with how and why the majority of 
people living in Myanmar access health care and the potential repercussions of clamping down on 
unregistered medicines. Secondly, it appears ignorant or disinterested in how the Ministry of 
Health and Sport’s (MOHS) (including the FDA) enactment of regulation, like other state agencies 
in Myanmar, follows a politics of fear and repression that publicly blame and penalise those such 
as Aunty Moe and U Kyaw for the (dis)functioning and fragmentary nature of health provision and 
the Myanmar State, more generally. Finally, it fails to engage with how state employees and drug 
shop vendors attempt to negotiate the enactment of regulation – partly through nalehmu, 
a mutual understanding – so as to minimise disruptions to their work and availability of cheaper 
medicines, while avoiding directly challenging social hierarchies and inequities. In this paper, we 
follow the aftermath of the FDA raid and foreground Myanmar’s broader history and the WHO’s 
AMR GAP, to elucidate these points.
Myanmar an authoritarian state: fear, rule of law, and Bamar Buddhist nationalism
Research has been conducted on drug resistance in Myanmar since at least the 1970s (R Htun Nyun 
et al., 1975; Sabai Phyu et al., 2005). In the 2010s, work on AMR was carried out through disease- 
specific programs (e.g. tuberculosis, malaria) spearheaded by non-governmental organisations and 
bilateral and multilateral organisations (The Global Fund, 2019; USAID, 2020). Only since the devel-
opment of the WHO GAP in 2015, however, has antibiotic resistance been framed by the MOHS as 
a matter of ‘national’ concern in need of increased regulatory measures. However, to talk of ‘national’ 
concern and proposed state-centric solutions in Myanmar is no straightforward matter. While the 
WHO GAP does not touch directly on the ongoing authoritarian role of Myanmar’s military in political 
governance, state sovereignty, and rule of law, here, we foreground historical and contemporary 
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aspects of Myanmar that are central to understanding how any NAP, particularly with relation to 
regulation of antibiotic, (dis)functions in practice (Broom, et al., 2020b), such as in the case of the FDA 
raid and events that followed it.
Myanmar’s democratically re-elected government, the National League for Democracy (NLD), has 
inherited a national territory and state that continues to grapple with the legacies of British 
colonialism, followed by 50 years of military rule. Many were quick to optimistically laud 
Myanmar’s economic opening up, NLD’s 2015 and 2020 election wins, and to support calls for the 
rule of law as part of democratisation (Cheesman, 2014). As the February 1st military coup demon-
strates, the democratisation of Myanmar is fragile. Since the early 1990s, the military imposed and 
attempted to manage Myanmar’s ‘transition’ to democracy. The result is a ‘hybrid regime’ (Stokke & 
Soe Myint Aung, 2020), where the NLD – or any other elected parties – must constantly negotiate 
with the military that has constitutionally mandated 25% of parliamentary seats, complete opera-
tional independence from Myanmar’s head of state, Aung San Suu Kyi, and the authority to appoint 
the heads of three key ministries, Border Affairs, Home Affairs, and Defence (Maung Aung Myoe, 
2014). Scholarly analyses draw attention to how the meaning and enactment of politics and the rule 
of law remain subject to the military’s ongoing role in state politics and everyday life (Cheesman, 
2014; Prasse-Freeman, 2015). This is not only evidenced by the recent military coup but also in how 
violence or its threat continues to play a central role in daily life in Myanmar, whether in the civil wars 
the military is waging with non-Bamar ethnic armed organisations, the exclusion of Rohingya as 
citizens, or the violent silencing of dissidents. Current enactments of laws and regulations share more 
in common with Myanmar’s military past and its slogan of ‘law and order’ than rule of law in 
democratic states where it is ‘ . . . associated with ideas and practices aimed at substantive [and 
political] legal equality . . .’ (Cheesman, 2014, p. 232). In other words, rule of law continues to serve 
the military’s aspirational order, which prioritises maintaining and expanding their Bamar Buddhist 
national sovereignty and security for the benefit of a minority of military and other elites (Sanchez, 
2020). Meanwhile, Aung San Suu Kyi and the NLD, more generally, have repeatedly attempted to 
either tacitly or explicitly oppose the military, such as their attempt in 2020 to reduce the military’s 
political power via changing the Constitution. However, in some cases, while referring to national 
security, rule of law, democracy, and justice, the NLD has also affirmed the military’s agenda, such as 
when Aung San Suu Kyi defended the military in the International Court of Justice in the Hague 
against accusations of crimes against humanity (Bowcott, 2019).
Many commentators have argued that Myanmar’s State as a whole has and continues to give 
precedence to the expansion and maintenance of its sovereignty, security, and integrity over the 
fulfilment of universal human rights and equality, improving standards of public health, welfare, and 
infrastructure for all those that reside within its borders (Oehlers, 2005; Prasse-Freeman & Latt, 2018; 
Skidmore & Wilson, 2008). While this is most evident for residents of Myanmar living in areas where 
the military continues to engage in civil wars or in negotiated and forced ceasefires, in many ways it 
is also the case for the majority of people living in Myanmar. During the military’s absolute 
authoritarian rule (1962–2011), increased investment and development of military resources and 
institutions paralleled the gradual run-down and fragmentation of state infrastructure and institu-
tions (Oehlers, 2005; Perry, 2007). While this certainly was the consequence of a weak state, scholars 
have also described not only deliberate negligence (Oehlers, 2005), but the military’s active denial of 
development and improvements to urban settlements and state infrastructure to ensure popula-
tions would not come to threaten their pursuit of ‘law and order’ (Perry, 2007; Sanchez, 2020; Seekins, 
2005; Seekins, 2009). The military accompanied such authoritarian means of social control with the 
threat of violence and state surveillance, all of which served to create a pervasive sense of fear, 
distrust, and paranoia amongst Myanmar’s citizens, as well as the military, civil servants, and state 
officials themselves (Skidmore, 2003). This continues in varying degrees to the present day, as is 
evident with the military’s recent coup that attempts to silence political dissent and claims for justice 
through violence.
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The legacy of the military’s rule has led to public health facilities and state regulatory institutions 
(like the FDA) that are characterised by corruption and underfunding, lacking all but basic staff, 
equipment, and consistent supplies of medicines. When patients visit public health facilities, they 
may have to gadaw – pay respect (‘special fees’) – in order to receive the available medicines or 
priority clinical appointments, in part as compensation for health staffs’ poor salaries. Gadaw 
practices have become an accepted norm for patients to essentially pay for services in the public 
sector that are otherwise unavailable, contributing to partially privatising the public sector. 
Furthermore, Myanmar’s citizens cope with the shortcomings of state institutions’ provision of health 
care through visiting street vendors and black markets for more affordable medical equipment and 
medicines (Oehlers, 2005). The lack of a national health insurance means that the majority of health 
financing occurs through out-of-pocket payments in the private sector (World Health Organization, 
2014). In sum, the underfunding and under resourcing of Myanmar’s public health infrastructure 
have created conditions where those already struggling with crippling poverty and low wages often 
perform gadaw practices, simply to access state service, as well as relying on private and poorly 
regulated provision of basic health care, and safe, quality assured medicines. Combined with the 
military’s ongoing role in everyday life, and a pervasive politics of fear, the majority of Myanmar’s 
citizens are left with limited options, except to cope and make do, or risk being taken before the law; 
the recent coup makes this all the more evident. Taken together, the coup poses significant 
challenges to the effective national implementation of global policies, such as the AMR GAP, and 
how their enactments are experienced by Myanmar’s citizens. This paper explores how small drug 
vendors that provide medicines to Yangon’s urban poor, FDA officials, and other state authorities 
negotiate the enactment of drug regulations, so that the enforcement of laws does not disrupt, at 
least in the short to mid-term, the sale of unregistered medicines, their livelihoods, and more 
broadly, Myanmar’s ‘law and order.’
Methods
This paper draws on ethnographic fieldwork at Sein Se Saing and interviews with various people 
involved in the pharmaceutical sector in Yangon. This approach allowed us to explore not only what 
people thought about the sale, access, and regulation of medicines, but also how these activities 
unfold in practice and how they correspond, or not, to Myanmar’s drug laws and AMR NAP. As part of 
participant observation, we also paid close attention to Burmese terms, particularly those related to 
the negotiation of Myanmar’s ‘law and order’. We include some of these terms as Burmese transli-
terations in this text to assist and remind readers that terms cannot be fully understood independent 
of the contexts and practices in which we observed and heard them.
YKZ and JSB conducted ethnographic fieldwork over nine months (January–September 2019) in 
various parts of Yangon, including at a small local wet market where Sein was located, and visited 
two large wholesale markets, and eight pharmaceutical companies. We also followed up some of 
these businesses’ clients, accompanying a few of them in their daily lives, including a clinician, a rural 
health worker, a nurse aid, a vet, and a rural health assistant. We conducted a series of in-depth semi- 
structured interviews with Aunty Moe and U Kyaw to supplement our ethnographic observations, to 
gain a greater degree of reflective discussion of what we observed and heard from them or others, as 
well as the relevant documents we surveyed (e.g. such as AMR policy and legal documents) (Given, 
2008, p.422–423). We interviewed several stakeholders, including two FDA employees, four indivi-
duals providing health services (e.g. from non-governmental organisations) in this setting, and six 
clinicians who worked for the public and private sectors. Interviews lasted between 30 and 120 min-
utes and focused on understanding participants’ lives, their reflections and experiences of laws and 
regulations, their understandings of health provision, and their awareness of antibiotic use or AMR. 
We also conducted media and documentary analysis concurrent to our fieldwork on topics related to 
regulation of medicines and AMR, drawing on various sources including social media sites, libraries, 
news, and reports. All interviews were conducted in Burmese, and when digitally recorded, were 
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transcribed, prior to thematic coding and analysis. When participants requested not to be recorded, 
we took extensive notes instead. YKZ and JSB discussed and reflected on field notes daily, and with 
CLH every week or two. Data analysis was conducted iteratively alongside fieldwork, allowing 
themes to be further challenged or corroborated in interviews or observation, as we gradually 
developed and refined more general or abstracted analytical codes. Throughout our research we 
prioritised being sensitive to the needs and concerns of our participants and the circumstances in 
which they lived and worked, and only engaged in interviews and participant observation when 
consent was granted. In order to protect our participants, we use pseudonyms for people and places. 
This study obtained ethical approval from the London School of Hygiene and Tropical Medicine.
Sustaining national (dis)order: the national drug law and Yangon’s poor
Sein is situated in one of Yangon’s large industrial workers’ neighbourhoods and has opened 7 days 
a week from 6 AM to 6 PM for over 15 years. Their customers are a mix of medical professionals 
buying supplies for their clinics, shops, and practices and residents of the township, most of whom 
are referred to by development organisations as the urban poor (Azam, 2014). The latter are 
composed of people who were forcedly displaced and resettled from central Yangon following 
various development projects or are rural-urban migrants that dramatically increased in number 
following Cyclone Nargis in 2008. The township where they reside and work is described in popular 
media as one of Yangon’s ‘most problematic’ townships due to poverty, crime, overpopulation, and 
lack of state infrastructure (e.g. sewerage and drainage, clean water), which contributes to frequent 
flooding and spread of infectious diseases (see Supplementary Material, Figures 1 and 2). Almost all 
of Sein’s customers are those who provide care and medicines to the urban poor of Yangon or are 
the urban poor themselves, subject to various forms of structural violence, including state neglect 
and market exploitation.
Sein has a registration license from the MOHS, which recognises them as a legal vendor of 
medicines. While the shop is registered with requisite state authorities, a large portion of the 
medicines they sell are unregistered with the FDA and are therefore, illegal, according to the 
updated 2018 National Drug Law (Union of Myanmar, 1992; Union of Myanmar 2018). This states 
that legal action (up to 7 years of jail or a fine) will be taken against the sale of drugs that are 
unregistered, fake, and dangerous or ‘determined as not fit for utilisation by the Ministry of Health’ 
(The Union of Myanmar, 2018). Although Aunty Moe and U Kyaw – as well as other drug vendors we 
observed and spoke with – were aware of this law, the fact that they do not literally follow it to the 
letter is not due to disregard for patient-consumer safety; quite the opposite. Their – and others’ – 
knowledge and ongoing experiences of Myanmar’s state repression, violence, and its focus on its 
security means they do not simply trust that registered medicines are necessarily safer than those 
that are not. They are aware that not only has the FDA been understaffed and underfunded, limiting 
their ability to do their work effectively, but the processes of drug registration also lack transparency 
and are commonly known to require gadaw fees. Despite this, Aunty Moe contended that this does 
not mean that the MOHS is unable to regulate and remove ‘dangerous’ medicines, as when 
chloramphenicol pills disappeared from pharmaceutical markets. The director of the FDA and the 
Department of Fisheries stated that chloramphenicol was not registered for import and was pro-
hibited for use in aquaculture (Shwe Yee San Myint, 2014a). We have not been able to locate publicly 
available information to corroborate these statements. This reflects a common trope in Myanmar; 
that being able to know laws and hence, what is illegal or not, is not a citizen’s right, or at least, not 
a self-evident matter. Whether this is intended or not as a means of social control, Myanmar’s citizens 
are kept in the dark about questions of legality, conferring a privilege of power to those with 
knowledge, potentially enabling them to exercise and enforce laws according to their whims 
(Cheesman, 2009; Prasse-Freeman, 2015). This also means that state employees can make claims 
to illegality where such laws may not exist or at least, not strictly in the ways they are articulated in 
practice. Thus, as Cheesman (2009, 2014) argues, in Myanmar law in practice serves as a means of 
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maintaining a particular order. In the case of medicines, this order determines what medicines are 
available, where, for whom, and how the state employees classify them, as well as who can afford to 
purchase and consume them. Hence, any general designation of Sein’s sales and its customers’ 
purchases of unregistered medicines and antibiotics without prescriptions as illegal, fails to under-
stand how rule of law in Myanmar actually (dis)functions in practice, through its limited investment 
in quality assurance measures, underpaid staff, and lack of affordable provision of medicines and 
care to its citizens. Aunty Moe and U Kyaw’s distrust of the state is not only is sensitive to this, but is 
part of sustaining this (dis)order through filling the ‘gaps’ that national drug laws (re)produce in 
enabling the classification of medicines and practices as illegal or not in the first place.
Shops like Sein sell unregistered medicines because they are cheaper than medicines registered 
with the FDA (Shwe Yee San Myint, 2014b). Such medicines are also available elsewhere, such as 
pharmaceutical chains or in clinics, where customers will also likely be charged a consultation fee of 
2–3 USD. The majority of residents in the vicinity of Sein earn 3 or less USD a day through minimum 
wage jobs or casual labour, and have little choice except to purchase cheaper unregistered 
Figure 1. Informal settlements in the outskirts of Yangon (taken by YKZ).
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medicines. Many state officials are aware of this, albeit not openly. This is the case of medical 
professionals who refer their patients on to providers like Sein when public health facilities they 
work in lack the requisite medicines, or they themselves purchase unregistered medicines for their 
own private practices. One example of the latter is Mya Myint, one of Sein’s top customers, 
a government employed rural health assistant in her village outside Yangon. Her meagre monthly 
salary at just over 1 lakh (70 USD, roughly the same as factory workers on minimum wage) is barely 
enough to support herself. Thus, like many other government employees (May Thandar Win, 2016), 
including medical consultants working in public hospitals, she has had little choice except to start up 
her own private practice.
Every 1–2 weeks Mya Myint visits Sein to purchase medicines in bulk of up to 5–6 lakhs (350–450 
USD), carrying them on her motorbike during her home visits, attending to the elderly, those too sick 
to leave home or who cannot travel to Yangon or another village for medical attention. For each visit, 
she charges between 5000 and 10,000 kyats (4–8 USD), almost the same cost as a clinician’s 
consultation fee in central Yangon. From these visits, she says she can earn significantly more than 
her government salary. Without the likes of Sein and their sale of unregistered medicines, and Mya 
Myint and her private practice, Yangon’s urban poor and those across Myanmar would lack afford-
able medicines and sufficient earnings. The state’s de- and underfunding of public health infra-
structure and other state institutions – including salaries, affordable medicines, and transparent 
processes for regulating them – means that policies such as the National Drug Law actively 
participate in creating the ‘necessity’ for shops like Sein to fill such ‘gaps’ in state provision for 
Yangon’s urban poor. They also contribute to sustaining the distrust Myanmar’s people harbour 
towards laws on paper (many of which they have not seen or heard of) and affect their meaning in 
everyday encounters.
Negotiating the rule of law: mutual understanding and paying respect
In line with Myanmar’s draft AMR NAP, during their unannounced inspections, the FDA has in 
addition to confiscating unregistered medicines began to reprimand drug shop owners for selling 
antibiotics without prescriptions. However, legally, the FDA can only take action against the sale of 
unregistered medicines and not the sale of antibiotics. So, the likes of Sein are confused when they 
are reprimanded by FDA inspectors for selling antibiotics when it’s not currently illegal to the extent 
of persecution to sell them over the counter without prescription.
Figure 2. A swamp near Sein (taken by JSB).
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Sein received two warning letters stating a mandatory three-month suspension of all operations 
and a termination of the shop’s registration license. U Kyaw and Aunty Moe were very upset and 
asked a friend, who had also received a warning letter, what he was going to do. Also distressed, he 
responded: ‘If my shop is closed, what are we going to eat and live with? I have to keep it open.’ 
U Kyaw and Aunty Moe then decided to visit the FDA, who denied sending the letters. Later that 
evening, two other shop owners came to discuss the situation, and speculated on whether the letters 
were ‘fakes’ and if someone else in authority, not based in the FDA, had sent them to ‘warn us’. Such 
reflection made it evident that the shop owners were less concerned with the regulations and 
whether or not they had broken them (selling unregistered medicines or antibiotics without 
prescriptions), and more concerned with why state officials had specifically targeted and caught 
them in particular.
All of them knew that state officials were aware of these illegal activities and typically turned 
a blind eye, so they were convinced that they must have disrespected one of the local authorities, 
and thus be ‘in their bad graces.’ After some deliberation, Aunty Moe concluded that they must 
approach a state official (SO) responsible for overseeing activities in the area. She was convinced that 
someone was upset because she had not once gone to the public hospital to gadaw to the SO. She 
postulated on several reasons as to why this may be the case.
One scandal they had heard involved Sabai (which also received a warning letter), a large drug 
shop with multiple branches, whose owner was sued by the FDA and received a jail sentence for 
having a large stock of unregistered medicines. However, rumour had it, the owner paid 150 lakhs 
($10,000) to the SO, which resulted in all the charges being dropped. When they eventually met the 
SO, they learned that this had actually happened under the previous SO. Despite this, rumours 
circulated that the current SO had reached a nalehmu with Sabai. Nalehmu is a discrete, mutual 
understanding based on relations of mutuality, obligation, and reciprocity that seeks to broker 
justice often outside the rule of law, whilst leaving intact existing social hierarchies and inequalities 
(Rhoads, 2020; Roberts, 2020). The outcome of the nalehmu was that Sabai would gadaw to the SO, 
and in return they could continue to stock and sell as many illegal medicines as they wanted, 
unhindered by the potential enactment of the national drug law, so long as they also took precau-
tions to avoid getting caught again.
The current SO was furious with this rumour as it had led to her receiving a warning from her 
superior. From this, Aunty Moe deduced that the raid had been intended for Sabai and had caught 
them as collateral damage with their unregistered medicines. She was right, Sabai had to gadaw to the 
SO. Similar to the shame the SO experienced when the rumour circulated about a gadaw relationship 
with Sabai, she was shamed again, this time in front of the inspectors and other state employees when 
they found unregistered medicines in Sein, a drug shop in an area under her jurisdiction; openly 
implicating her in allowing illegal activities to take place. Aunty Moe told us that the owner of Sabai, 
and the SO, came to a nalehmu, and the SO warned everyone else, ‘If you are selling unregistered 
medicines, maybe you should do it quietly’. In doing so, the SO recognised Sein and the other drug 
shops’ precarious circumstances, and emphasised that they need to recognise hers too.
Two months later, Sein was back to its pre-raid activities. When we inquired about the penalty from 
the warning letters, U Kyaw merely responded, ‘We have come to a nalehmu with the SO.’ Despite the 
raid and the activities that followed, Aunty Moe was not angry with the state officials. She said:
I don’t blame her [SO] too much. It’s hard to be a doctor here. You have to work hard and their basic salary is only 
around 2-3 lakhs [150$/month] and they always have to do overtime. So, they try to get money like this to survive.
Later, we learnt from interviews with our FDA informants that prior to any drug shop raids they have 
to seek permission from a wide range of state actors, some of whom also participate in their raids. 
This confirmed Aunty Moe and the other drug shop owners’ suspicions that it was the SO and not the 
FDA, who had sent them the letters.
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Evading and breaking the law to broker (in)justice
Reaching a nalehmu agreement that involves gadaw is one of the ways that Sein and other drug 
shops negotiate with state authorities to evade the full penalties of the National Drug Law. 
Preferable to getting caught in the first place, Aunty Moe and U Kyaw employ a number of strategies 
to evade the authorities. Primary amongst these is receiving notification of raids in advance, so they 
can close their shop. For Sein, these come from Aunty Moe’s brother who works as a state employee 
or from a phone call from a fellow shop owner. However, when they have insufficient forewarning, 
like in the raid described earlier, U Kyaw moves any unregistered medicines and others that they are 
not licensed to sell into hidden storage at the back of their shop. Aunty Moe told us such measures 
are normal amongst drug shops. A senior member of the FDA attested to such practices in a local 
news article:
We try to control the sale of illegal drugs at the market, but we cannot stop all of it. When we go to these shops 
to inspect for illegal medicines, store owners move their stock before we come. (Shwe Yee San Myint, 2014b)
One of our FDA respondents corroborated this statement by stating that the department lacked staff 
and budget to do frequent raids and more than one or two antimicrobial awareness raising activities 
per year. Thus, breaking and negotiating the application of the law through nalehmu often is the 
most practical way for all parties involved to broker relative justice.
A few months later, we witnessed another FDA raid. This time Aunty Moe and U Kyaw were ready. 
Her brother had already notified them in advance, so they were able to remove their shop sign and 
close up, leaving what looked like an abandoned roadside cubicle to any passer-by. Meanwhile, 
U Kyaw stood nearby, listening for any signs of the inspectors coming and going, notifying others of 
the authorities’ intended raid. This time they evaded getting caught and bringing further shame to 
the SO, fulfilling their part of the nalehmu agreement with her. The SO appeared to fulfil her part; 
they did not receive another warning letter or have to gadaw. This allowed vendors to continue to 
sell unregistered medicines and authorities to continue to conduct their raids in the neighbourhood. 
Myanmar’s national (dis)order is not only sustained by shops like Sein and practices like Mya Myint’s, 
which act as a way to fill the ‘gaps’ in healthcare provision, but also through state agents like the SO, 
who actively participate in breaking the law to allow such provision to continue.
Conclusion
The WHO prescribes nation-states as those responsible for translating its AMR GAP policies into 
action, particularly the regulation of access, use, and quality of antibiotics. Our ethnographic 
exploration of drug regulation in practice pushes back against the sufficiency of such technical 
prescriptions (e.g. reduce illegal sales of antibiotics) to effectively achieve the National Drug Law and 
NAP AMR’s apparent intended ends. We demonstrate this by contextualising our empirical findings 
through historical and contemporary aspects of Myanmar daily life. Shops like Sein’s sale of 
unregistered medicines and Mya Myint’s private medical practice provide where the Myanmar 
state does not. FDA and other state authorities, and drug shop vendors, are well aware of the limits 
of the Myanmar state’s health-care infrastructure, inadequate investment in drug quality assurance 
and low employee salaries. They understand that the illegal sale of medicines is necessary because of 
the state’s lack of provision of affordable medicines but also to sustain the livelihoods of the likes of 
U Kyaw and Aunty Moe, as well as to supplement state officials’ own meagre salaries. They all also 
know that not only does the state lack infrastructure to effectively enact regulations according to the 
letter of the drug law but also, when attempts are made to enforce it, they typically end up serving 
the military and state authorities’ interests over Myanmar’s citizens’ health and welfare. Hence, as we 
have described, distrust of Myanmar’s state and fears of its authorities are commonplace, an ongoing 
legacy of the military’s authoritarian approach to governing everyday life in Myanmar, as amply 
evidenced in the recent coup. So, drug vendors, the FDA, and other state officials discreetly negotiate 
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the enactment of drug laws through fragile nalehmu and gadaw practices to maintain a semblance 
of following the rule of law to the letter, while avoiding bringing shame to more senior state officials 
and openly challenging Myanmar’s ‘law and order’. In doing so, they find ways to cope and make do 
with the little they have, while brokering small acts of justice through ensuring Yangon’s poor 
continue to have access to affordable medicines. We therefore call for those working to promote the 
regulation of medicines, such as antibiotics, to attend more carefully and explicitly in policy design 
and implementation not only to a state’s infrastructural abilities to enact laws but also its political 
priorities, approaches to political governance, and the relevant effectiveness of its state-market 
arrangement to the provision of affordable quality assured health care. In Myanmar, this means 
questioning the effectiveness and harm of promoting a state-centric approach, such as the regula-
tory aspects of its AMR NAP, as well as considering cautious engagement and decentralised work 
with the many non-state ‘experts’ that are already in place (e.g. civil society and other ethnic minority 
organisations, local researchers). If not, they may run the risk of contributing to, if not intensifying, 
already existing health disparities and social injustices whilst also failing to generate intended 
outcomes, such as meaningful changes to antibiotic sales and reductions in resistance.
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